Myocarditis, an inflammatory condition affecting the myocardium (heart muscle), is often caused by viral infections and represents a significant cardiovascular health concern. Among the viruses implicated in myocarditis, enteroviruses, adenoviruses, and parvovirus B19 are common culprits. Viral myocarditis can result from direct viral invasion or as an immune response to the infection. The clinical presentation of viral myocarditis varies, ranging from mild flu-like symptoms to severe heart failure. Diagnosing myocarditis involves a combination of clinical evaluation, cardiac imaging, and laboratory tests. Endomyocardial biopsy may be performed in severe cases for definitive diagnosis. Treatment includes supportive care, antiviral medications, and immunosuppressive therapy in certain cases. Preventing viral myocarditis involves practicing good hygiene, vaccination against preventable viral infections, and managing underlying conditions that may predispose individuals to the development of myocarditis. Research into the pathogenesis and treatment options for viral myocarditis continues to advance our understanding of this complex cardiovascular infection, offering hope for improved outcomes and therapies in the future.